Literature DB >> 25795403

Old drugs, new tricks for triple-negative breast cancer.

Lisa Carey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25795403     DOI： 10.1016/S1470-2045(15)70108-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Targeted Therapies in Breast Cancer: New Approaches and Old Challenges.

Authors:  Isabell Witzel; Volkmar Müller
Journal:  Breast Care (Basel)       Date:  2015-06-18       Impact factor: 2.860

2.  Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.

Authors:  Nicholas A Taylor; Sarah C Vick; Michael D Iglesia; W June Brickey; Bentley R Midkiff; Karen P McKinnon; Shannon Reisdorf; Carey K Anders; Lisa A Carey; Joel S Parker; Charles M Perou; Benjamin G Vincent; Jonathan S Serody
Journal:  J Clin Invest       Date:  2017-08-21       Impact factor: 14.808

3.  Regulation of AMPK-related glycolipid metabolism imbalances redox homeostasis and inhibits anchorage independent growth in human breast cancer cells.

Authors:  Lin Yang; Zihao He; Jingyue Yao; Renxiang Tan; Yejin Zhu; Zhiyu Li; Qinglong Guo; Libin Wei
Journal:  Redox Biol       Date:  2018-04-18       Impact factor: 11.799

4.  Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple-Negative Breast Cancer Tumor Growth.

Authors:  Yan Liu; Yehui Zhou; Xinxing Ma; Liming Chen
Journal:  Adv Sci (Weinh)       Date:  2021-01-06       Impact factor: 16.806

5.  Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.

Authors:  Carey K Anders; Mark G Woodcock; Benjamin G Vincent; Jonathan S Serody; Amanda E D Van Swearingen; Dominic T Moore; Maria J Sambade; Sonia Laurie; Alexander Robeson; Oleg Kolupaev; Luz A Cuaboy; Amy L Garrett; Karen McKinnon; Kristen Cowens; Dante Bortone; Benjamin C Calhoun; Alec D Wilkinson; Lisa Carey; Trevor Jolly; Hyman Muss; Katherine Reeder-Hayes; Rebecca Kaltman; Rachel Jankowitz; Vinay Gudena; Oludamilola Olajide; Charles Perou; E Claire Dees
Journal:  J Immunother Cancer       Date:  2022-02       Impact factor: 12.469
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.